Discussion in 'Latest ME/CFS Research' started by Kyla, Sep 12, 2015.
Now we just need someone to do this sort of review for every other finding in ME.
Ie - compare findings based on disease definition and differences in methodology.
I think this would be a game changer in terms of figuring out which findings are consistent.
I wonder why we didn't spot this when it was published in July.
It could be the Hemispherx-sponsored review paper that we were expecting.
Hemispherx are also supposed to be publishing the results of their latest Ampligen/NKCC/CFS research, in about a month's time, according to a tweet about their recent press conference that I came across yesterday.
I wondered the same thing @Bob
It popped up in a google scholar alert from last night, as if it had just been published online. (Or at least just been indexed).
And yes, I think this is the ampligen sponsored paper
Short news article about the review:
Hemispherx Biopharma Reports Low NK Cell Activity in Chronic Fatigue Syndrome (CFS) and Relationship to Disease Symptoms
Ampligen(R) Increases NK Activity More Than 100% in Vitro in a CFS Patient Population
You can also try a Google Site Search
Separate names with a comma.